TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Increase of heart rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: decrease in perceived stress
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: mean reduction in urgency incontinence episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perceptions of improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: improvement in severity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma concentrations of total cysteine fractions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: PImax improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of severe wasting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: ADCOMS decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recruitment of RMU muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: KCCQ-23 Overall Summary Score (OSS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: CKD progression
Endpoint domain: Mortality/survival
Primary endpoint: Reduction in geometric mean personal PM2.5
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in geometric mean kitchen PM2.5
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Coronary heart disease 10-year risk scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in depression, anxiety, and OCD symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skindex-16 emotions subscale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: access-site related vascular complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Reduced risk of hospitalization or death
Endpoint domain: Mortality/survival
Primary endpoint: Mean Energy Availability (EA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive Restraint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of BPH development
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of BPH symptom progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proportion of students choosing neurosurgery majors
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: clinical practice abilities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle torque of fractured leg knee extensors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ureteral injury prevention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: simulation overview procedure time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: scratching of humerus cartilage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Amygdala responses to face emotions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Anxious-arousal attenuation for fear faces
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Abdominal edema reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of foreign bodies on abutment surfaces
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bacterial colony growth on agar plates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Improvement rate of ischemic area stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Distance of six-minute walking test (6MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exophthalmometry reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: New-onset esotropia
Endpoint domain: Adverse events/effects
Primary endpoint: Preoperative esotropia increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Odds of collecting mosquitoes indoors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Indoor temperatures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Carbon dioxide levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: opioid-related harm
Endpoint domain: Adverse events/effects
Primary endpoint: Safety of FCM imaging during paediatric heart surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Effectiveness of FCM in identifying conduction tissue regions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: refusal of pseudo-underage patron buyers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: glucose iAUC reduction at 1 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: insulin iAUC reduction at 1 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: plantarflexor spasticity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: dorsiflexor muscles strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Normalized SmO2 during low-load contractions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient adherence to disease treatment and cure
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: night-time frequency at 4 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of jaw muscle activity during sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healthier gut microbiota
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of chronic pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prolonged post-surgical opioid use
Endpoint domain: Adverse events/effects
Primary endpoint: London Chest Activity of Daily Living (LCADL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: white matter hyperintensity volume progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of primary endpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time to complete hemostasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean patient discomfort score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of RCD manipulations
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Cumulative incidence of brain metastases at 2 years
Endpoint domain: Mortality/survival
Primary endpoint: college adjustment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Mean UCVA and BCVA improvements at 24 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrence of disease
Endpoint domain: Adverse events/effects
Primary endpoint: reductions in cannabis consequences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reductions in cannabis-impaired driving
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increased physical activity (PA)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of RCC units transfused per year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average pre-transfusion hemoglobin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Average transfusion interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean myocardial salvage index (MSI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median CMR-derived FIS (percentage of LV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean left ventricular ejection fraction (LVEF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transition to oral feeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: First‐pass success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Related complications
Endpoint domain: Adverse events/effects
Primary endpoint: modified MASI score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intensity of subjective effects (alertness and feeling stoned)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acute memory impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Psychosis-like effects
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of action of lignocaine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total number of nonsteroidal antiinflammatory drugs needed
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Diabetes distress
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Improvement or stabilization in neuropathic progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in score for mNIS + 7
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in score for Norfolk QOL‐DN
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: EFT performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: shoulder functional performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: shoulder internal rotation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median PPi concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median PLP concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median % predicted distance walked on the 6‐Minute Walk Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average area of exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percentage of participants remaining aparasitemic
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Trial retention
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Diet quality scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Anxiety scores after surgery
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time-to-correct-placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Mean number of adenomas per patient
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Patient interest in auricular acupressure
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Step length during obstacle crossing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in HDRS‐17
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AQC's clearance compared to ALC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Probability of antibiotic prescribing for ARTI
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: increase in fruit consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increase in vegetable consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decrease in consumption frequency of unhealthy snacks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patient satisfaction with delivery experience
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Postprandial GlycA concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Postprandial IL-6 concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: levels of total cortisol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Birth registration of children
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: future uncertainty worsening
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning
Primary endpoint: physical functioning worsening
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: emotional functioning worsening
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning
Primary endpoint: change in ppFEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: adverse events (headache)
Endpoint domain: Adverse events/effects
Primary endpoint: quantitative scoring improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of scars
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: full dose intensity (DI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: progression-free survival (PFS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Causal association between gut microbiota and TFM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Knowledge of potential complications of screening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of corneal TEAEs
Endpoint domain: Adverse events/effects
Primary endpoint: generalized anxiety symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: erythema index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: treatment-associated side effects
Endpoint domain: Adverse events/effects
Primary endpoint: CDR_SOB scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: caseload-level improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patient improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immune response to Tdap and meningococcal vaccines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: day 5 eGFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: rate of DGF/SGF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: 12 months patient survival
Endpoint domain: Mortality/survival
Primary endpoint: Improvements in bowel symptoms
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: NEI-VFQ-25 scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Postoperative shivering frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Website visit frequency
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Improvements in diet and physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PFIQ7 total score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ICIQ-SF values
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Integration of medication use in everyday lives
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Trust in healthcare providers
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Use of digital decision support tools for medication reviews
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: mean load to failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical operative time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: screw access deviation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: one-time satisfaction rate
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Increase in lymphocyte count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Rate of thyroid hormone replacement therapy after lobectomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Mean postoperative thyroid stimulating hormone level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Time to thyroid hormone replacement therapy-initiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: microbial translocation markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: T-cell activation markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: need for transfer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median percent reductions in primary BOEs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fitness score tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: gamma glutamyl transferase (GGT) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: fatty liver index (FLI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Anticipatory cortisol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: global RVBA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of pure lumbar Z joint pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: CAP score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient satisfaction with doctors' technical skills
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of dengue
Endpoint domain: Mortality/survival
Primary endpoint: VAS scores for dysmenorrhoea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS scores for chronic pelvic pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum levels of CA-125
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: incidence of negative postoperative behavior changes
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: distal locking time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: distal locking radiation exposure time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: first success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Average number of hospitalization days per patient-year
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Inpatient-care costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Social well-being challenges
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Ostomy-specific issues
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Symptomatic VTE
Endpoint domain: Mortality/survival
Primary endpoint: average depth of chest compressions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: chronic PTHs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patient-oriented composite endpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive attitudes towards the IUD
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Informational support for decision-making about the IUD
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: average increase of nasal height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pharmacokinetic and clinical response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GI symptoms prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Postoperative interleukin (IL)-2 concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of NK cells in PBMC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Surgical clerks' self-confidence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing